HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hugh A Gelabert Selected Research

Thoracic Outlet Syndrome (Syndrome, Thoracic Outlet)

1/2022The evolving role of endovascular therapy in the management of arterial thoracic outlet syndrome.
1/2021A novel technique for transaxillary resection of fully formed cervical ribs with long-term clinical outcomes.
10/2018Transaxillary decompression of thoracic outlet syndrome patients presenting with cervical ribs.
7/2007Combining ultrasonography and electromyography for botulinum chemodenervation treatment of thoracic outlet syndrome: comparison with fluoroscopy and electromyography guidance.
5/2007Differentiation of thoracic outlet syndrome from treatment-resistant cervical brachial pain syndromes: development and utilization of a questionnaire, clinical examination and ultrasound evaluation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hugh A Gelabert Research Topics

Disease

5Thoracic Outlet Syndrome (Syndrome, Thoracic Outlet)
01/2022 - 05/2007
3Venous Insufficiency
05/2022 - 07/2012
3Thrombosis (Thrombus)
05/2019 - 03/2007
2Pain (Aches)
10/2021 - 07/2007
2Upper Extremity Deep Vein Thrombosis
01/2020 - 03/2007
2Aneurysm (Aneurysms)
05/2019 - 05/2010
2Hematoma
10/2018 - 07/2012
1Fistula
10/2021
1Wounds and Injuries (Trauma)
10/2021
1Fungemia
10/2021
1Neuroendocrine Tumors (Neuroendocrine Tumor)
10/2021
1Venous Thrombosis (Deep-Vein Thrombosis)
01/2020
1Paralysis (Palsy)
05/2018
1Ischemia
01/2017
1Cysts
01/2017
1Infections
10/2014
1Aortic Aneurysm (Aneurysm, Aortic)
11/2013
1Anaphylaxis (Anaphylactic Shock)
11/2013
1Hemorrhage
07/2011
1Rupture
05/2010
1Renal Insufficiency (Renal Failure)
05/2010
1Dystonia (Limb Dystonia)
07/2007
1Hyperplasia
10/2003
1Retinoblastoma (Glioblastoma, Retinal)
10/2003
1Vascular System Injuries
10/2003

Drug/Important Bio-Agent (IBA)

2Warfarin (Coumadin)FDA LinkGeneric
07/2012 - 07/2011
1P-2 (P 2)IBA
01/2022
1Polytetrafluoroethylene (Teflon)FDA Link
10/2014
1VancomycinFDA LinkGeneric
10/2014
1Heparin (Liquaemin)FDA LinkGeneric
11/2013
1Protamines (Protamine Sulfate)FDA Link
11/2013
1AnticoagulantsIBA
07/2011
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
07/2011
1Fibrinolytic Agents (Antithrombotic Agents)IBA
03/2007
1reteplaseFDA Link
03/2007
1Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
03/2007
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
10/2003
1MitogensIBA
10/2003
1Mitogen-Activated Protein KinasesIBA
10/2003
1Proteins (Proteins, Gene)FDA Link
10/2003
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2003

Therapy/Procedure

3Decompression
01/2021 - 05/2018
2Ligation
05/2022 - 10/2021
2Therapeutics
01/2022 - 07/2012
2Stents
05/2019 - 10/2003
2Radiofrequency Ablation
08/2013 - 07/2013
2Aftercare (After-Treatment)
05/2010 - 05/2007
1Ablation Techniques
05/2022
1Endovascular Procedures
01/2022
1Operative Time
10/2021
1Renal Dialysis (Hemodialysis)
10/2021
1Treatment Delay
01/2020
1Patient Readmission
10/2018
1Vascular Surgical Procedures
01/2017
1Thrombectomy
01/2017
1Catheters
10/2014
1Conservative Treatment
07/2012
1Nephrectomy
05/2010
1Nerve Block (Nerve Blocks)
07/2007